Binding members for IgE molecules

Details for Australian Patent Application No. 2008215926 (hide)

Owner AstraZeneca AB MedImmune Limited

Inventors Monk, Phillip David; Dobson, Claire Louise; Cochrane, Duncan; VonWachenfeldt, Karin; Eriksson, Per-Olof Fredrik; Cohen, Suzanne

Agent Davies Collison Cave

Pub. Number AU-B-2008215926

PCT Pub. Number WO2008/099188

Priority 60/901,305 15.02.07 US

Filing date 15 February 2008

Wipo publication date 21 August 2008

Acceptance publication date 19 July 2012

International Classifications

C07K 16/42 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against immunoglobulins (anti-idiotypic antibodies)

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

A61P 37/08 Drugs for immunological or allergic disorders

Event Publications

13 August 2009 PCT application entered the National Phase

  PCT publication WO2008/099188 Priority application(s): WO2008/099188

19 July 2012 Application Accepted

  Published as AU-B-2008215926

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008215944-Method of treating a gas stream

2008215924-Heterocyclic derivatives as M3 muscarinic receptors